Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FWUVP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,574
Award facts
- Contract value 100% obligated
- $17,574.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status.
This award represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. As a critical pharmaceutical supplier within the federal supply chain, DMS Pharmaceutical Group has established a robust portfolio delivering an extensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to military healthcare facilities nationwide. EXPAREL, a liposomal bupivacaine formulation, is a specialized pharmaceutical product used for postsurgical pain management, supporting the Defense Department's healthcare delivery requirements.
Quick answers
Who was awarded contract SPE2DB25FWUVP?
SPE2DB25FWUVP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWUVP worth?
The government has obligated $17,574 on SPE2DB25FWUVP.
Is contract SPE2DB25FWUVP an order under another contract?
Yes. SPE2DB25FWUVP is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUVP competed?
The extent of competition for SPE2DB25FWUVP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award